Literature DB >> 1829612

Continuous hepatic artery infusion (CHAI) as treatment of liver metastases. Are the complications worth it?

M M Kemeny1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1829612     DOI： 10.2165/00002018-199106030-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  9 in total

1.  A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.

Authors:  D C Hohn; R J Stagg; M A Friedman; J F Hannigan; A Rayner; R J Ignoffo; P Acord; B J Lewis
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

2.  Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer.

Authors:  R von Roemeling; W J Hrushesky
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

3.  A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver.

Authors:  L D Wagman; M M Kemeny; L Leong; J J Terz; L R Hill; J D Beatty; W A Kokal; D U Riihimaki
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

4.  Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma.

Authors:  W J Hrushesky; R von Roemeling; R M Lanning; J T Rabatin
Journal:  J Clin Oncol       Date:  1990-09       Impact factor: 44.544

5.  Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma.

Authors:  N Kemeny; J Daly; P Oderman; M Shike; H Chun; G Petroni; N Geller
Journal:  J Clin Oncol       Date:  1984-06       Impact factor: 44.544

6.  Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.

Authors:  M M Kemeny; H Battifora; D W Blayney; G Cecchi; D A Goldberg; L A Leong; K A Margolin; J J Terz
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

7.  Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries.

Authors:  M M Kemeny; D Goldberg; J D Beatty; D Blayney; S Browning; J Doroshow; L Ganteaume; R L Hill; W A Kokal; D U Riihimaki
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

8.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

9.  Circadian timing of cancer chemotherapy.

Authors:  W J Hrushesky
Journal:  Science       Date:  1985-04-05       Impact factor: 47.728
  9 in total
  1 in total

Review 1.  Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.

Authors:  P Chrisp; D McTavish
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.